Up to 30 percent of all medicines sold in Africa are counterfeit. This is an alarming percentage, given that people’s lives are at stake. Pharmaceutical manufacturers are required to take more responsibility for this problem as it is often difficult to distinguish between the legitimate and fake drug. Pagemark Africa can help pharmaceutical manufacturers to protect their brand by empowering consumers and brand managers to tell the difference between the authentic and counterfeit drug.
Some Important Facts:
- Product diversion and black-marketing significantly impact a company’s brand strength, total revenue, and shareholder value.
- Should the product integrity be violated, it can be a public safety issue, thereby placing the manufacturer at risk.
- Trade in fake medicines is growing internationally.
- Companies are looking toward technology in order to change the way track and trace solutions are being deployed and managed.
Why Pagemark Africa and Using the Pelta™ Solution for Pharmaceutical and Healthcare Suppliers:
- Products can be tracked and traced in the supply chain using geolocation technology.
- Brand owners would be able to protect their brand.
- Law enforcement would be able to distinguish between the fake and authentic product, thereby limiting the amount of counterfeit medicines entering their country.
- The Pelta™ solution can easily fit into any production supply chain.
- The Pelta™ code cannot be copied by counterfeiters.
- Pelta™ codes use existing 2D Data Matrix GS1 or QR barcode (ISO/IEC 18004) specifications, so manufacturers or packaging specialists can easily migrate to Pelta™ codes with little to no change in their physical coding/printing systems.